These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 17532678)

  • 21. Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine.
    Teggi R; Gatti O; Sykopetrites V; Quaglieri S; Benazzo M; Bussi M
    Acta Otorhinolaryngol Ital; 2014 Oct; 34(5):349-53. PubMed ID: 25709150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Betahistine by Patient-Reported Outcomes and its Tolerability Profile in Indian Patients with Vestibular Vertigo.
    Kirtane MV; Biswas A
    J Assoc Physicians India; 2017 Apr; 65(4):18-24. PubMed ID: 28527159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study.
    Parfenov VA; Golyk VA; Matsnev EI; Morozova SV; Melnikov OA; Antonenko LM; Sigaleva EE; Situkho MI; Asaulenko OI; Popovych VI; Zamergrad MV
    PLoS One; 2017; 12(3):e0174114. PubMed ID: 28358888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cinnarizine: A Contemporary Review.
    Kirtane MV; Bhandari A; Narang P; Santani R
    Indian J Otolaryngol Head Neck Surg; 2019 Nov; 71(Suppl 2):1060-1068. PubMed ID: 31750127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo.
    Mira E; Guidetti G; Ghilardi L; Fattori B; Malannino N; Maiolino L; Mora R; Ottoboni S; Pagnini P; Leprini M; Pallestrini E; Passali D; Nuti D; Russolo M; Tirelli G; Simoncelli C; Brizi S; Vicini C; Frasconi P
    Eur Arch Otorhinolaryngol; 2003 Feb; 260(2):73-7. PubMed ID: 12582782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative efficacy of betaserc and cinnarizine of vertigo in patients with migraine].
    Amelin AV; Skoromets AA; Gonchar MA; Tumelevich BCh; Nikitin KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(5):43-8. PubMed ID: 12789824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study.
    Melnikov OA; Lilenko SV; Nauta J; Ouwens MJ
    Curr Med Res Opin; 2015 Nov; 31(11):1951-62. PubMed ID: 26121560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of an antivertiginous combination preparation of cinnarizine and dimenhydrinate on event-related potentials, reaction time and psychomotor performance--a randomized, double-blind, 3-way crossover study in healthy volunteers.
    Philipova D; Tzenova B; Iwanowitsch A; Bognar-Steinberg I
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):218-31. PubMed ID: 15124980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comparison of the Effects and Side Effects of Oral Betahistine with Injectable Promethazine in the Treatment of Acute Peripheral Vertigo in Emergency.
    Motamed H; Moezzi M; Rooyfard AD; Angali KA; Izadi Z
    J Clin Med Res; 2017 Dec; 9(12):994-997. PubMed ID: 29163732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of betahistine on patient-reported outcomes in routine practice in patients with vestibular vertigo and appraisal of tolerability: experience in the OSVaLD study.
    Benecke H; Pérez-Garrigues H; Bin Sidek D; Uloziene I; D K; Sondag E; Theeuwes A;
    Int Tinnitus J; 2010; 16(1):14-24. PubMed ID: 21609908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous Lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial.
    Marill KA; Walsh MJ; Nelson BK
    Ann Emerg Med; 2000 Oct; 36(4):310-9. PubMed ID: 11020677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is cinnarizine/betahistine combination superior to respective monotherapies in treatment of vertigo? Comment on a randomized triple-blind placebo-controlled trial.
    Amini K; Taghizadeh-Ghehi M
    Eur J Clin Pharmacol; 2020 Apr; 76(4):607-608. PubMed ID: 31932873
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on "Is cinnarizine/betahistine combination superior to respective monotherapies in treatment of vertigo? A randomized triple-blind placebo-controlled trial".
    Majdi A; Naseri Alavi SA
    Eur J Clin Pharmacol; 2020 Apr; 76(4):609-610. PubMed ID: 31932872
    [No Abstract]   [Full Text] [Related]  

  • 34. Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study.
    Oosterveld WJ
    J Laryngol Otol; 1984 Jan; 98(1):37-41. PubMed ID: 6363584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study.
    Pianese CP; Hidalgo LO; González RH; Madrid CE; Ponce JE; Ramírez AM; Morán LM; Arenas JE; Rubio AT; Uribe JO; Abiuso J; Hanuch E; Alegría J; Volpi C; Flaskamp R; Sanjuán AP; Gómez JM; Hernández J; Pedraza A; Quijano D; Martínez C; Castañeda JR; Guerra OJ; F GV
    Otol Neurotol; 2002 May; 23(3):357-63. PubMed ID: 11981396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Trimetazidine versus betahistine in vestibular vertigo. A double blind study].
    Kluyskens P; Lambert P; D'Hooge D
    Ann Otolaryngol Chir Cervicofac; 1990; 107 Suppl 1():11-9. PubMed ID: 2240994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of vertigo with a homeopathic complex remedy compared with usual treatments: a meta-analysis of clinical trials.
    Schneider B; Klein P; Weiser M
    Arzneimittelforschung; 2005; 55(1):23-9. PubMed ID: 15727161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of betahistine dihydrochloride compared with cinnarizine on induced vestibular nystagmus.
    Cullen JR; Hall SJ; Allen RH
    Clin Otolaryngol Allied Sci; 1989 Dec; 14(6):485-7. PubMed ID: 2612026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine.
    Sokolova L; Hoerr R; Mishchenko T
    Int J Otolaryngol; 2014; 2014():682439. PubMed ID: 25057270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study.
    Băjenaru O; Roceanu AM; Albu S; Zainea V; Pascu A; Georgescu MG; Cozma S; Mărceanu L; Mureşanu DF
    Int J Gen Med; 2014; 7():531-8. PubMed ID: 25506241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.